|BRIEF RESEARCH COMMUNICATION
|Year : 2016 | Volume
| Issue : 4 | Page : 489-494
Multiple radiation-induced late changes seen in pelvis in a single patient
Ayush Naik, Virendra Bhandari, KL Gupta, Mehlam Kausar
Department of Radiation Oncology, Sri Aurobindo Medical College and PG Institute, Indore, Madhya Pradesh, India
|Date of Web Publication||12-Jul-2016|
401, Samyak Towers, 16/3, Old Palasia, Indore, Madhya Pradesh
Source of Support: None, Conflict of Interest: None
Background: Radiation sequelae can be early or late depending on the duration of occurrence. Early reactions are temporary, but late reactions tend to be permanent and occur many years after treatment. Late reactions can be seen in skin, subcutaneous tissue, muscle, and bone in the irradiated area. Materials and Methods: We present here a report in which we saw all the late reactions in a single patient, 18 years after radiotherapy to pelvis for cancer cervix. Results: Our patient had bone fracture, new bone formation, bone marrow widening, muscle hypertrophy, subcutaneous fibrosis, and angiokeratoma after 18 years of radiotherapy to pelvic area. Conclusion: All these types of late toxicities are rarely seen in the same patient and we could not find any such reports in the literature.
Keywords: Bone, late radiation toxicity, muscle, skin and pelvis, radiotherapy to pelvic area
|How to cite this article:|
Naik A, Bhandari V, Gupta K L, Kausar M. Multiple radiation-induced late changes seen in pelvis in a single patient. Med J DY Patil Univ 2016;9:489-94
|How to cite this URL:|
Naik A, Bhandari V, Gupta K L, Kausar M. Multiple radiation-induced late changes seen in pelvis in a single patient. Med J DY Patil Univ [serial online] 2016 [cited 2022 Oct 5];9:489-94. Available from: https://www.mjdrdypu.org/text.asp?2016/9/4/489/186058
| Introduction|| |
Radiation toxicity can be divided into early and late. Nausea, skin reactions, diarrhea, and neutropenia are early temporary effects whereas late effects are connective tissue fibrosis, bone fractures, skin lesions, and secondary malignancy, which occur months or years after radiotherapy. The etiology for long-term sequelae is complex and involves a cascade of cellular, vascular, and cytokine changes induced by radiation. The organs at risk during pelvic radiotherapy are colon, small bowel, bladder, ureters, urethra, genital organs, spinal cord, skin, soft tissue, muscles, bones, vasculature, nerves, and lymphatic system.
One or more late radiation toxicity can be seen in survivors. Here, we present a case where late reactions were seen in all tissues, 18 years after radiotherapy to pelvis. The patient had bone fractures, new bone formation, widening of joint space with fluid, fatty marrow, muscle hypertrophy, subcutaneous fibrosis, and angiokeratoma developing simultaneously. All these late radiation toxicities are rarely seen in the same patient. We could not find any similar case reported in the literature.
| Materials and Methods|| |
A 49-year-old female presented with burning micturition, fever, inability to walk, and multiple skin lesions over pelvic area, which were not responding to symptomatic treatment.
In the past, she had squamous cell carcinoma cervix and received external beam radiotherapy (EBRT) 50 Gy/25 fractions with anterior and posterior portals delivered on alternate days on telecobalt unit followed by single fraction of intracavitary brachytherapy 25 Gy at point A on low dose rate (LDR) unit till October 1994. Since then, the patient was on regular follow-up and is loco regionally controlled.
In May 2011, pain in pelvic area started with difficulty in walking. Pelvis X-ray revealed pathological fracture at right superior ischeo-pubic ramus and new bone formation in inferior ischeo-pubic rami [Figure 1]. In June 2011, the patient developed multiple red, firm warty lesions over vulvar and pubic area [Figure 2] with episodes of leucorrhea. The patient was locoregionally controlled. In September 2012, she developed low back pain and progressive difficulty in walking. Her magnetic resonance imaging (MRI) pelvis showed diffuse hyperintense signals in sacral ala and left iliac bone with widening of left sacroiliac joint space and enlargement of psoas muscle along with increased signals in ipsilateral iliacus piriformis and proximal adductor muscles. A loculated cyst was also seen in left iliacus muscle. Fatty marrow changes were evident in all pelvic bones [Figure 3]a and [Figure 3]b. There was no evidence of disease at primary site except for vaginal wall thickening, extensive subcutaneous fibrosis in pelvic region, and lower abdominal muscles, and multiple vulvar lesions A whole body positron emission tomography scan was done, which showed increased uptake (standardized uptake value 8.4) in sclerotic lesions of left sacroiliac joints with increased joint space suggesting inflammatory sacro-ilietis. Fluerodeoxy glucose (FDG) nonavid cortical break was seen in anterior pillar of right acetabulum, inferior pubic ramus, and sacral ala indicating pathological fracture. Soft tissue hypertrophy was seen in left psoas, iliacus, and piriform muscles without uptake. No uptake was seen in the vulvar lesions.
|Figure 3: (A and B) Magnetic resonance imaging showing fatty marrow, diffuse hyperintense signals in sacral ala, and left iliac bone with widening of left sacroiliac joint and muscle changes|
Click here to view
Biopsy done from one warty lesion over pubis showed hyperplastic epidermis with focal hyperkeratosis and papillary dermis showing numerous dilated vascular spaces forming angiomatous mass confirming radiation-induced angiokeratoma [Figure 4]a and [Figure 4]b. On follow-up on last month, she had increased pain in pelvis, inability to walk, increased number of vulvar lesions, and bilateral lower limb edema.
|Figure 4: (A and B) Hyperplastic epidermis with focal hyperkeratosis and papillary dermis showing numerous dilated vascular spaces forming angiomatous|
Click here to view
| Discussion|| |
Radiation therapy remains to be a mainstay of treatment in various malignant conditions. The frequency of radiation-induced adverse effect has decreased significantly with the advent of newer technologies of radiation delivery, which allows more conformity of the target tissue and homogenous dose distribution and also because of increased knowledge of tissue response to radiation.
Effects of radiation on living tissue can be divided into early and late effects, which show huge variation in terms of different patterns of response to fractionations and dose-response relations. Acute damage may be completely reversible and is rapidly repaired by rapid proliferation of stem cells. Only after a delay of months or years late, effects appear and these can be seen predominantly in slowly proliferating tissues, such as lung, kidney, heart, liver, and central nervous system. Late damage may improve, but it is never completely repaired and these late changes might result from a combination of vascular damage and loss of parenchymal cells.
Musculoskeletal complication of radiotherapy are often discovered incidentally when radiographic investigations are ordered to check the presence of recurrence or metastatic disease. Radiation doses which are used routinely for the treatment for cervical cancer (CaCx) or carcinoma prostate do not result in acute injury to bone. Therefore, late radiation-induced changes in bones are characteristic and a long latent period is usually present before these changes are detected because of slow metabolic turnover of bones. These late effects include damage to osteoblasts, decreased matrix formation, and osteopenia along with osteoradionecrosis, pathologic fractures, and radiation-induced neoplasms, which are usually seen years after radiation. The threshold of radiation-induced changes in the bone is thought to be 3000 cGy, with death of cells usually occurring at 5000 cGy.,
Repair of damaged bone takes place with deposition of bone on unresorbed trabeculae, which can be seen as focal areas of increased opacity in close proximity to areas of mottled bone with osteopenia on radiographs and the patient can be initially asymptomatic, but ultimately symptoms appear due to osteonecrosis or stress insufficiency fractures. These changes can be attributed to the decrease in bone blood flow. This reduction in bone vascularity combined with impaired bone formation from irradiated osteoblasts results in decrease in bone density and thus resulting in fracture. Radiation can lead to obliteration endartitis and endothelial cell cytoplasmic vacuolization, which in turn leads to luminal narrowing in the haversian system resulting in decreased blood flow. Also, the fact that osteoblast proliferation is affected by radiation resulting in decreased bone matrix formation and bone atrophy. Thus as an end result of radiation injury, osteoclast bone resorption can continue without concomitant bone formation resulting in decrease in bone density and thus fractures., Risk factors for radiation-induced pathologic factors of bones include total radiation dose, dose given per fraction, area of bone receiving radiation, size of radiation portals periosteal stripping of bone, female gender, older age, postmenopausal women, osteoporosis, and use of chemotherapy.,,
The bony structures of pelvis are frequently included in radiation portals while treating CaCx or other gynecological malignancy. Radiation-induced changes in pelvis usually include osteopenia, increased bone density and widening and irregularity of the sacroiliac joints, and pelvic insufficiency fractures (PIFs). These can be detected on radiographic imaging and it is important to differentiate these radiation-induced changes from metastatic disease. On routine X-rays, typical pattern of osteopenia is seen along with patchy areas of sclerosis and increased bone densities. Sacroiliac joints may also appear widened and irregular with sclerosis. PIFs are common in patients who have received prior radiation to pelvis. PIF usually occurs near the areas of radiation osteitis and in close proximity to the weight bearing joints, especially adjacent to sacroiliac joints. Computed tomography scans or MRI pelvis has a higher sensitivity for the detection of PIFs.,,, The 5-year incidence of PIF in patients who have been previously irradiated patients is found to be 2.1-13%.,, Usually, patients having PIF are asymptomatic, but these may present with new onset of pain. These painful lesions may persist for months to years in symptomatic patients. Risk factors for PIF include dose >50 Gy, osteopenia, corticosteroid use, and older age.,, Clinical presentation of our patient along with changes seen on X-rays and MRI, and the presence of risk factors for PIF favors our diagnosis of radiation-induced late changes.
EBRT delivered by conventional fractionation cause no damage or very little damage to mature muscle fibers., Dose fractionation schedule is an important determinant of muscle injury. Karasek et al. noted that the most important determinant of delayed late muscle morbidity in patient of soft tissue sarcoma after radiotherapy is the volume of tissue receiving more than 55 Gy. Withers et al. performed a retrospective analysis on 676 patients treated with EBRT for carcinoma tonsil and reported that 66% of late muscle complications appeared in the first 4 years after treatment injury and concluded that larger total dose and larger dose per fraction were the main factors defining the rate of complication whereas overall treatment time was not. Phillips et al. studied human muscle response after irradiation, and observed muscle degeneration and vacuolization associated with a loss of capillaries 2-4 months after doses of 20 Gy.
Muscle changes in response to radiation can be impressive and acute changes on MRI can be seen by bright T2-weighted signal intensity in the treated field indicating inflammation and/or edema. Chronic or late changes usually seen as discrete areas of fibrosis and muscle atrophy often with overlying volume deficits corresponding to the radiation treatment portals. Lefaix et al. demonstrated that muscle fibrosis is a common and late side effect of radiation on skeletal muscle. Fibrosis is usually irreversible and results in chronic pain deformity and impaired mobility in severe cases. Delayed necrosis of striated muscle can also be seen after receiving therapeutic doses of radiation because of damage to capillaries and connective tissue. Several reports  also described patients of Hodgkin's lymphoma having myopathy within the radiated muscles.
Most common histopathological changes due to postradiation myopathy are presence of nemalin rods. Other changes include variation in muscle fiber size, disorganized architecture, nuclear variations, and infiltration by adipocytes. Pathophysiology underlying these muscle changes is due to damage to vessel and blood capillaries and their consequent ischemia along with the inflammation. The endothelial cell are most sensitive to radiation and they exhibit swelling and necrosis acutely followed by intimal proliferation and increase in collagen content and its deposition, which along with ischemia and inflammation leads to the development of muscle fibrosis and which in turn causes a nonspecific repair reaction which causes alteration in muscle parenchyma., Although rare, progressive muscle damage can continue for up to 10 years following treatment. Radiation also affects muscle satellite cells by impairing their activation, proliferation, and differentiation by preventing their mitosis by causing breaks in DNA strands, which leads to the inhibition of regeneration and muscle hypertrophy.
Changes seen in our patient can be explained by the fact that relatively large daily fractionated doses were administered to the pelvic muscles. Also, with the decision to use two-field technique, the pelvic muscle might have received larger dose pre fraction and cumulative dose than if 3 or 4 field techniques have been used.
Skin reaction to radiation can be classified as early (before 6 months) or late (<6 months). Early reactions include transient erythema causing vasodilatation, increased vascular permeability and edema, epilation, and skin dryness is also seen due to damage to hair follicles and sebaceous glands, these changes are followed by dry desquamation, pruritus, scaling, hyperpigmentation, and moist desquamation usually seen after 2-3 weeks of radiotherapy. Late reactions include hyperpigmentation and/or hypopigmentation, epidermal and/or dermal atrophy, skin dryness, loss of sweat glands and duct, alopecia, telectangasia, nuclear atypia, nuclear atypia of basal keratinocytes and melanocytes, dyskeratosis, loss of rete ridges, disappearance of the epidermal basement membrane, fibrin formation along the dermoepidermal junction, and decreased numbers of upper dermal blood capillaries ,,, hyperplasia of epidermis/dermis, hyperkeratosis, fibrosis, luminal narrowing or obliteration of vessels, radiation-induced neoplasm. Radiation-induced angiokeratoma is a rare phenomenon to occur and a recognized complication,,,, angiokeratomas are benign lesions thought to be telangiectasias with secondary epithelial proliferation. Histologically, angiokeratomas are characterized by ectatic capillaries at the dermoepidermal junction, with reactive hyperkeratosis, acanthosis and focal papillomatosis of the overlying epidermis. Proposed mechanisms responsible for the development of angiokeratomas include primary degeneration of the vascular elastic tissue, increased venous pressure with consequent destruction of elastic fibers resulting in over distension, and chronic inflammation causing phlebectasia. Radiation-induced damage to blood vessels along with decreased blood return due to larger field sized used in treatment could lead to increase in venous blood pressure, which in turn is known to cause angiokeratoma. A possible mechanism is vascular injury because of radiotherapy-induced free radical production. Blood vessels are relatively resistant to radiation, hence this toxicity is very rare to occur. Patients having angiokeratomas are mostly asymptomatic, but sometimes patient may present with complains of dyspareunia, bleeding or pus discharge from some of the lesions, and these increase in number and size slowly in radiated area. Therapy is sometimes required when there is continuous bleeding, progressive pain, or anxiety. In symptomatic cases, therapy is indicated and treatment modalities include surgical excision, electrocauterization, cryotherapy, or laser treatment, the choice of which largely depends on size of the lesion.
Our patient also showed vulvar lesions gradually increasing in number and size with discharge, but no bleeding resulting in dyspareunia and psychological burden to patient and was offered treatment in form of surgery, but patient refused surgery, hence a decision to treat conservatively was taken.
| Conclusion|| |
Presence of late toxicities involving bones, muscle, and skin lesion in the form of vulvar angiokeratoma in a single patient is very rare and we could not find any such case in literature.
The most likely cause for the development of these late effects in the present case was the schedule and technique used for the delivery of radiation in an overweight patient with antero-posterior separation of 26 cm leading to increased integral dose.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| References|| |
Hall EJ, Giaccia AJ. Clinical response of normal tissues. Radiobiology for the Radiologist. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 340.
Howland WJ, Loeffler RK, Starchman DE, Johnson RG. Postirradiation atrophic changes of bone and related complications. Radiology 1975;117(3 Pt 1):677-85.
Ollivier L, Brisse H, Leclere J. Bone marrow imaging: follow-up after treatment in cancer patients. Cancer Imaging 2002;2: 90-92.
Rubin P, Prabhasawat D. Characteristic bone lesions in post-irradiated carcinoma of the cervix. Metastases versus osteonecrosis. Radiology 1961;76:703-17.
Paling MR, Herdt JR. Radiation osteitis: A problem of recognition. Radiology 1980;137:339-42.
Hopewell JW. Radiation-therapy effects on bone density. Med Pediatr Oncol 2003;41:208-11.
Williams HJ, Davies AM. The effect of X-rays on bone: A pictorial review. Eur Radiol 2006;16:619-33.
Ahmad M, Sampair C, Nazmul-Hossain AN, Khurana N, Nerness A, Wutticharoenmongkol P. Therapeutic doses of radiation alter proliferation and attachment of osteoblasts to implant surfaces. J Biomed Mater Res A 2008;86:926-34.
Lin PP, Schupak KD, Boland PJ, Brennan MF, Healey JH. Pathologic femoral fracture after periosteal excision and radiation for the treatment of soft tissue sarcoma. Cancer 1998;82:2356-65.
Cannon CP, Ballo MT, Zagars GK, Mirza AN, Lin PP, Lewis VO, et al.
Complications of combined modality treatment of primary lower extremity soft-tissue sarcomas. Cancer 2006;107:2455-61.
Lin PP, Boland PJ, Healey JH. Treatment of femoral fractures after irradiation. Clin Orthop Relat Res 1998;352:168-78.
De Santos LA, Libshitz HI. Adult bone. In: Libshitz HI, editor. Diagnostic Roentgenology of Radiotherapy Change. Baltimore, MD: Williams & Wilkins; 1979. p. 137-50.
Cooper KL, Beabout JW, Swee RG. Insufficiency fractures of the sacrum. Radiology 1985;156:15-20.
Abe H, Nakamura M, Takahashi S, Maruoka S, Ogawa Y, Sakamoto K. Radiation-induced insufficiency fractures of the pelvis: Evaluation with 99mTc-methylene diphosphonate scintigraphy. AJR Am J Roentgenol 1992;158:599-602.
Ikushima H, Osaki K, Furutani S, Yamashita K, Kishida Y, Kudoh T, et al.
Pelvic bone complications following radiation therapy of gynecologic malignancies: Clinical evaluation of radiation-induced pelvic insufficiency fractures. Gynecol Oncol 2006;103:1100-4.
Oh D, Huh SJ, Nam H, Park W, Han Y, Lim do H, et al.
Pelvic insufficiency fracture after pelvic radiotherapy for cervical cancer: Analysis of risk factors. Int J Radiat Oncol Biol Phys 2008;70:1183-8.
Tai P, Hammond A, Dyk JV, Stitt L, Tonita J, Coad T, et al.
Pelvic fractures following irradiation of endometrial and vaginal cancers-a case series and review of literature. Radiother Oncol 2000;56:23-8.
Blomlie V, Rofstad EK, Talle K, Sundfør K, Winderen M, Lien HH. Incidence of radiation-induced insufficiency fractures of the female pelvis: Evaluation with MR imaging. AJR Am J Roentgenol 1996;167:1205-10.
Ogino I, Okamoto N, Ono Y, Kitamura T, Nakayama H. Pelvic insufficiency fractures in postmenopausal woman with advanced cervical cancer treated by radiotherapy. Radiother Oncol 2003;68:61-7.
Gillette EL, Mahler PA, Powers BE, Gillette SM, Vujaskovic Z. Late radiation injury to muscle and peripheral nerves. Int J Radiat Oncol Biol Phys 1995;31:1309-18.
Withers HR, Peters LJ, Taylor JM, Owen JB, Morrison WH, Schultheiss TE, et al.
Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: Patterns of fractionation study of radiobiology. Int J Radiat Oncol Biol Phys 1995;33:563-8.
Karasek K, Constine LS, Rosier R. Sarcoma therapy: Functional outcome and relationship to treatment parameters. Int J Radiat Oncol Biol Phys 1992;24:651-6.
Phillips JL. Benak S, Ross G. Ultrastructural and cellular effects of ionizing radiation. Front Radiat Ther Oncol 1972;6:21-43.
Richardson ML, Zink-Brody GC, Patten RM, Koh WJ, Conrad EU. MR characterization of post-irradiation soft tissue edema. Skeletal Radiol 1996;25:537-43.
Lefaix JL, Delanian S, Leplat JJ, Tricaud Y, Martin M, Hoffschir D, et al.
Radiation-induced cutaneo-muscular fibrosis (III): Major therapeutic efficacy of liposomal Cu/Zn superoxide dismutase. Bull Cancer 1993;80:799-807.
Furby A, Béhin A, Lefaucheur JP, Beauvais K, Marcorelles P, Mussini JM, et al.
Late-onset cervicoscapular muscle atrophy and weakness after radiotherapy for Hodgkin disease: A case series. J Neurol Neurosurg Psychiatry 2010;81:101-4.
Kogan A, Pushchinska G, Seidman R. Myopathy in post-radiation cervico-scapular syndrome. Neurol Bull 2011;3:25-32.
Zeman W, Soloman M. Effects of radiation on striated muscle. In: Berdjis CC, editor. Pathology of Irradiation. Baltimore, MD: Williams and Wilkins; 1971. p. 171-85.
Welsh JS, Torre TG, DeWeese TL, O'Reilly S. Radiation myositis. Ann Oncol 1999;10:1105-8.
Jurdana M. Radiation effects on skeletal muscle. Radiol Oncol 2008;42:15-22.
Fajardo LF. Skin Pathology of Radiation Injury. New York: Masson Publishing; 1982. p. 186-200.
Archambeau JO, Pezner R, Wasserman T. Pathophysiology of irradiated skin and breast. Int J Radiat Oncol Biol Phys 1995;31:1171-85.
Kaanders JH, Ang KK. Early reactions as dose-limiting factors in radiotherapy. Semin Radiat Oncol 1994;4:55-67.
Warren S. Radiation effects on the skin. In: Helwig EB, Mostofi FK, editors. The Skin. Baltimore, MD: Williams & Wilkins; 1971. p. 261-78.
Smith BL, Chu P, Weinberg JM. Angiokeratomas of the vulva: Possible association with radiotherapy. Skinmed 2004;3:171-2.
Haidopoulos DA, Rodolakis AJ, Elsheikh AH, Papaspirou I, Diakomanolis E. Vulvar angiokeratoma following radical hysterectomy and radiotherapy. Acta Obstet Gynecol Scand 2002;81:466-7.
Bhagan LB, Knaus JV. Concurrent diagnosis of vulvar angiokeratoma with recurrent squamous cell carcinoma after radical vulvectomy and radiation therapy. Gynecol Oncol Case Rep 2012;2:80-2. Atherton DJ, Moss C. Naevi and other developmental defects. In: Rook's Textbook of Dermatology. Oxford: Blackwell Science; 2004. p. 15.87-15.90.
Rees R, Freeman A, Malone P, Garaffa G, Muneer A, Minhas S. Case study: The surgical management of angiokeratoma resulting from radiotherapy for penile cancer. ScientificWorldJournal 2009;9:339-42.
[Figure 1], [Figure 2], [Figure 3], [Figure 4]